Migreen kliinilised uuringud osariigis Tennessee
8 uuringut haiguse Migreen jaoks otsivad osalejaid osariigis Tennessee.
Linnad osariigis Tennessee
Ametlik uuringutekst (inglise keeles)
Study of EVO756 in Adults With Migraine
- Campbell Clinical Research, Franklin
VärbamineFaas 2
Vanused 18–64 · Kõik sood · Uuendatud 2. okt 2026 · NCT07616128MMA Embolization for Refractory Chronic Migraine
- Semmes Murphey Foundation, Memphis
Värbamine
Vanused 18–65 · Kõik sood · Uuendatud 25. sept 2026 · NCT06735833A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Access Clinical Trials Inc /ID# 270280, Nashville
VärbamineFaas 3
Vanused 12–17 · Kõik sood · Uuendatud 22. sept 2026 · NCT06810505Responding With Evidence and Access for Childhood Headaches
- University of Tennessee Health Science Center/ LeBonheur Children's Hospital, Memphis
Värbamine
Vanused 10–17 · Kõik sood · Uuendatud 21. sept 2026 · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Vanderbilt Medical Center, Nashville
VärbamineFaas 4
Vanused 18–70 · Kõik sood · Uuendatud 16. sept 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Access Clinical Trials, Inc. /ID# 228002, Nashville
VärbamineFaas 3
Vanused 6–17 · Kõik sood · Uuendatud 14. sept 2026 · NCT05125302Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
- Clinical Research Associates, Inc., Nashville
VärbamineFaas 2
Vanused 18–65 · Kõik sood · Uuendatud 2. sept 2026 · NCT07646613A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- WR-ClinSearch, LLC, Chattanooga
- Access Clinical Trials, Inc, Nashville
- Clinical Research Associates, Inc., Nashville
VärbamineFaas 3
Vanused 18–75 · Kõik sood · Uuendatud 20. aug 2026 · NCT07645924Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.